|
| WT1 p53 and p16 expression in the diagnosis of low and highgrade serous ovarian carcinomas and their relation to prognosis |
|
https://doi.org/10.18632/oncotarget.24530
Luis Felipe Sallum, Liliana Andrade, Susana Ramalho, Amanda Canato Ferracini, Rodrigo de Andrade Natal, Angelo Borsarelli Carvalho Brito, Luis Otávio Sarian, and Sophie Derchain
|
| 15818-15827 |
|
| DEC205 mediates local and systemic immune responses to Helicobacter pylori infection in humans |
|
https://doi.org/10.18632/oncotarget.24574
Masahide Kita, Kenji Yokota, Chihiro Kageyama, Susumu Take, Kazuyoshi Goto, Yoshiro Kawahara, Osamu Matsushita, and Hiroyuki Okada
|
| 15828-15835 |
|
| Human cancer cells utilize mitotic DNA synthesis to resist replication stress at telomeres regardless of their telomere maintenance mechanism |
|
https://doi.org/10.18632/oncotarget.24745
Özgün Özer, Rahul Bhowmick, Ying Liu, and Ian D. Hickson
|
| 15836-15846 |
|
| GPX2 promotes development of bladder cancer with squamous cell differentiation through the control of apoptosis |
|
https://doi.org/10.18632/oncotarget.24627
Taku Naiki, Aya Naiki-Ito, Keitaro Iida, Toshiki Etani, Hiroyuki Kato, Shugo Suzuki, Yoriko Yamashita, Noriyasu Kawai, Takahiro Yasui, and Satoru Takahashi
|
| 15847-15859 |
|
| Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cells |
|
https://doi.org/10.18632/oncotarget.19335
Robert J Allaway, Matthew D Wood, Sondra L Downey, Stephanie J Bouley, Nicole A Traphagen, Jason D Wells, Jaya Batra, Sir Norman Melancon, Carol Ringelberg, William Seibel, Nancy Ratner, and Yolanda Sanchez
|
| 15860-15875 |
|
| Efficacy of continuous versus intermittent subglottic secretion drainage in preventing ventilatorassociated pneumonia in patients requiring mechanical ventilation: A singlecenter randomized controlled trial |
|
https://doi.org/10.18632/oncotarget.24630
Hiroko Fujimoto, Osamu Yamaguchi, Hajime Hayami, Mika Shimosaka, Sayaka Tsuboi, Mitsunori Sato, Shigeo Takebayashi, Satoshi Morita, Mari Saito, Takahisa Goto, and Kiyoyasu Kurahashi
|
| 15876-15882 |
|
| Transcriptional orchestration of mitochondrial homeostasis in a cellular model of PGC1related coactivatordependent thyroid tumor |
|
https://doi.org/10.18632/oncotarget.24633
Solenne Dumont, Soazig Le Pennec, Audrey Donnart, Raluca Teusan, Marja Steenman, Catherine Chevalier, Rémi Houlgatte, and Frédérique Savagner
|
| 15883-15894 |
|
| Transcriptome and proteome profiling reveals stressinduced expression signatures of imiquimodtreated Tasmanian devil facial tumor disease DFTD cells |
|
https://doi.org/10.18632/oncotarget.24634
Richard Wilson, Jac C. Charlesworth, Lynn M. Corcoran, Anthony T. Papenfuss, Bruce A. Lyons, Gregory M. Woods, and Cesar Tovar
|
| 15895-15914 |
|
| Recruitment of lysine demethylase 2A to DNA double strand breaks and its interaction with 53BP1 ensures genome stability |
|
https://doi.org/10.18632/oncotarget.24636
Murilo T.D. Bueno, Marta Baldascini, Stéphane Richard, and Noel F. Lowndes
|
| 15915-15930 |
|
| Premature ovarian aging in BRCA carriers: a prototype of systemic precocious aging |
|
https://doi.org/10.18632/oncotarget.24638
Irit Ben-Aharon, Mattan Levi, David Margel, Rinat Yerushalmi, Shulamith Rizel, Shlomit Perry, Eran Sharon, Noa Hasky, Ronit Abir, Benny Fisch, Ana Tobar, Ruth Shalgi, and Salomon Marcello Stemmer
|
| 15931-15941 |
|
| Ectopic expression of transcription factor BATF3 induces Bcell lymphomas in a murine Bcell transplantation model |
|
https://doi.org/10.18632/oncotarget.24639
Christian Weiser, Mina V. Petkova, Benjamin Rengstl, Claudia Döring, Dorothee von Laer, Sylvia Hartmann, Ralf Küppers, Martin-Leo Hansmann, and Sebastian Newrzela
|
| 15942-15951 |
|
| Uev1AUbc13 promotes colorectal cancer metastasis through regulating CXCL1 expression via NFкB activation |
|
https://doi.org/10.18632/oncotarget.24640
Zhaojia Wu, Heather Neufeld, Eminao Torlakovic, and Wei Xiao
|
| 15952-15967 |
|
| Promotion of malignant phenotype after disruption of the threedimensional structure of cultured spheroids from colorectal cancer |
|
https://doi.org/10.18632/oncotarget.24641
Jose M. Piulats, Jumpei Kondo, Hiroko Endo, Hiromasa Ono, Takeshi Hagihara, Hiroaki Okuyama, Yasuko Nishizawa, Yasuhiko Tomita, Masayuki Ohue, Kouki Okita, Hidejiro Oyama, Hidemasa Bono, Takashi Masuko, and Masahiro Inoue
|
| 15968-15983 |
|
| The role and gene expression profile of SOCS3 in colorectal carcinoma |
|
https://doi.org/10.18632/oncotarget.23477
Xing Dong, Jing Wang, Bo Tang, Yeng-Xue Hao, Ping-Yang Li, Shi-Yong Li, and Pei-Wu Yu
|
| 15984-15996 |
|
| Quantitative parameters in dynamic contrastenhanced magnetic resonance imaging for the detection and characterization of prostate cancer |
|
https://doi.org/10.18632/oncotarget.24652
Cheng Wei, Bowen Jin, Magdalena Szewczyk-Bieda, Stephen Gandy, Stephen Lang, Yilong Zhang, Zhihong Huang, and Ghulam Nabi
|
| 15997-16007 |
|
| Cancer reversion with oocyte extracts is mediated by cell cycle arrest and induction of tumour dormancy |
|
https://doi.org/10.18632/oncotarget.24664
Norazalina Saad, Ramiro Alberio, Andrew D. Johnson, Richard D. Emes, Tom C. Giles, Philip Clarke, Anna M. Grabowska, and Cinzia Allegrucci
|
| 16008-16027 |
|
| Arsenic trioxidemediated suppression of miR1825p is associated with potent antioxidant effects through upregulation of SESN2 |
|
https://doi.org/10.18632/oncotarget.24678
Liang-Tin Lin, Shin-Yi Liu, Jyh-Der Leu, Cheng-Yuan Chang, Shih-Hwa Chiou, Te-Chang Lee, and Yi-Jang Lee
|
| 16028-16042 |
|
| ADAM17 inhibition enhances platinum efficiency in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.24682
Nina Hedemann, Christoph Rogmans, Susanne Sebens, Daniela Wesch, Manuel Reichert, Dirk Schmidt-Arras, Hans-Heinrich Oberg, Ulrich Pecks, Marion van Mackelenbergh, Jörg Weimer, Norbert Arnold, Nicolai Maass, and Dirk O. Bauerschlag
|
| 16043-16058 |
|
| Store operated calcium entry is altered by the inhibition of receptors tyrosine kinase |
|
https://doi.org/10.18632/oncotarget.24685
Noémie Emeriau, Marie de Clippele, Philippe Gailly, and Nicolas Tajeddine
|
| 16059-16073 |
|
| Analysis of the PI3KAKTmTOR pathway in penile cancer: evaluation of a therapeutically targetable pathway |
|
https://doi.org/10.18632/oncotarget.24688
Anthony Adimonye, Elzbieta Stankiewicz, Sakunthala Kudahetti, Giorgia Trevisan, Brendan Tinwell, Cathy Corbishley, Yong-Jie Lu, Nick Watkin, and Daniel Berney
|
| 16074-16086 |
|
| A gene expression signature predicts recurrencefree survival in meningioma |
|
https://doi.org/10.18632/oncotarget.24498
Adriana Olar, Lindsey D. Goodman, Khalida M. Wani, Nicholas S. Boehling, Devi S. Sharma, Reema R. Mody, Joy Gumin, Elizabeth B. Claus, Frederick F. Lang, Timothy F. Cloughesy, Albert Lai, Kenneth D. Aldape, Franco DeMonte, and Erik P. Sulman
|
| 16087-16098 |
|
| Prediagnostic biomarkers of metabolic dysregulation and cancer mortality |
|
https://doi.org/10.18632/oncotarget.24559
Tomi Akinyemiju, Justin Xavier Moore, Suzanne E. Judd, Maria Pisu, Michael Goodman, Virginia J. Howard, Leann Long, Monika Safford, Susan C. Gilchrist, and Mary Cushman
|
| 16099-16109 |
|
| Type II RAF inhibitor causes superior ERK pathway suppression compared to type I RAF inhibitor in cells expressing different BRAF mutant types recurrently found in lung cancer |
|
https://doi.org/10.18632/oncotarget.24576
Amir Noeparast, Philippe Giron, Sylvia De Brakeleer, Carolien Eggermont, Ulrike De Ridder, Erik Teugels, and Jacques De Grève
|
| 16110-16123 |
|
| Overlap at the molecular and immunohistochemical levels between angioimmunoblastic Tcell lymphoma and a subgroup of peripheral Tcell lymphomas without specific morphological features |
|
https://doi.org/10.18632/oncotarget.24592
Rebeca Manso, Julia González-Rincón, Manuel RodrÃguez-Justo, Giovanna Roncador, Sagrario Gómez, Margarita Sánchez-Beato, Miguel A. Piris, and Socorro M. RodrÃguez-Pinilla
|
| 16124-16133 |
|
| Regulation of breast cancer induced bone disease by cancerspecific IKKβ |
|
https://doi.org/10.18632/oncotarget.24743
Silvia Marino, Ryan T. Bishop, Mattia Capulli, Antonia Sophocleous, John G. Logan, Patrick Mollat, Barbara Mognetti, Luca Ventura, Andrew H. Sims, Nadia Rucci, Stuart H. Ralston, and Aymen I. Idris
|
| 16134-16148 |
|
| Tracking cellular and molecular changes in a speciesspecific manner during experimental tumor progression in vivo |
|
https://doi.org/10.18632/oncotarget.24598
Emilie Indersie, Katarzyna B. Hooks, Caroline Capdevielle, Monique Fabre, Nathalie Dugot-Senant, Angélique Desplat, Sébastien Lepreux, Aksam Merched, Christophe F. Grosset, and Martin Hagedorn
|
| 16149-16162 |
|
| Caloric restriction delays yeast chronological aging by remodeling carbohydrate and lipid metabolism altering peroxisomal and mitochondrial functionalities and postponing the onsets of apoptotic and liponecrotic modes of regulated cell death |
|
https://doi.org/10.18632/oncotarget.24604
Anthony Arlia-Ciommo, Anna Leonov, Adam Beach, Vincent R. Richard, Simon D. Bourque, Michelle T. Burstein, Pavlo Kyryakov, Alejandra Gomez-Perez, Olivia Koupaki, Rachel Feldman, and Vladimir I. Titorenko
|
| 16163-16184 |
|
| Establishment and characterization of two cabazitaxelresistant prostate cancer cell lines |
|
https://doi.org/10.18632/oncotarget.24609
Kazuaki Machioka, Kouji Izumi, Yoshifumi Kadono, Hiroaki Iwamoto, Renato Naito, Tomoyuki Makino, Suguru Kadomoto, Ariunbold Natsagdorj, Evan T. Keller, Jian Zhang, and Atsushi Mizokami
|
| 16185-16196 |
|
| Analysis of hematological parameters as prognostic markers for toxicity and survival of 223Radium treatment |
|
https://doi.org/10.18632/oncotarget.24610
Asha Leisser, Marzieh Nejabat, Markus Hartenbach, Reza Agha Mohammadi Sareshgi, Shahrokh Shariat, Gero Kramer, Michael Krainer, Marcus Hacker, and Alexander R. Haug
|
| 16197-16204 |
|
| The Wilms’ tumor gene1 is a prognostic factor in myelodysplastic syndrome: a meta analysis |
|
https://doi.org/10.18632/oncotarget.23671
Yanan Jiang, Lin Liu, Jinhuan Wang, Zeng Cao, and Zhigang Zhao
|
| 16205-16212 |
|
| An open label singlearmed exploratory study of apatinib a novel VEGFR2 tyrosine kinase inhibitor in patients with relapsed or refractory nonHodgkin lymphoma |
|
https://doi.org/10.18632/oncotarget.23806
Ling Li, Sa Xiao, Lei Zhang, Xin Li, Xiaorui Fu, Xinhua Wang, Jingjing Wu, Zhenchang Sun, Xudong Zhang, Yu Chang, Feifei Nan, Jiaqin Yan, Zhaoming Li, Mengyuan Shi, Ken H. Young, and Mingzhi Zhang
|
| 16213-16219 |
|
| Polymorphisms in BER genes and risk of breast cancer: evidences from 69 studies with 33760 cases and 33252 controls |
|
https://doi.org/10.18632/oncotarget.23804
Lele Qiao, Xiaoshan Feng, Gongping Wang, Bo Zhou, Yantong Yang, and Mengxiang Li
|
| 16220-16233 |
|
| Potential therapeutic targets of TP53 gene in the context of its classically canonical functions and its latest noncanonical functions in human cancer |
|
https://doi.org/10.18632/oncotarget.24611
Toshimichi Tanaka, Masahiko Watanabe, and Keishi Yamashita
|
| 16234-16247 |
|
| Signaling lymphocytic activation molecules Slam and cancers: friends or foes |
|
https://doi.org/10.18632/oncotarget.24575
Gregory Fouquet, Ingrid Marcq, Véronique Debuysscher, Jagadeesh Bayry, Amrathlal Rabbind Singh, Abderrahmane Bengrine, Eric Nguyen-Khac, Mickael Naassila, and Hicham Bouhlal
|
| 16248-16262 |
|
| Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b who discontinued prior treatment with NS5A inhibitorincluding regimens due to adverse events |
|
https://doi.org/10.18632/oncotarget.24620
Tatsuo Kanda, Shin Yasui, Masato Nakamura, Shingo Nakamoto, Koji Takahashi, Shuang Wu, Reina Sasaki, Yuki Haga, Sadahisa Ogasawara, Tomoko Saito, Kazufumi Kobayashi, Soichiro Kiyono, Yoshihiko Ooka, Eiichiro Suzuki, Tetsuhiro Chiba, Hitoshi Maruyama, Mitsuhiko Moriyama, and Naoya Kato
|
| 16263-16270 |
|
| Correction: A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a metaanalysis |
|
https://doi.org/10.18632/oncotarget.24998
Zeming Liu, Wen Zeng, Tianwen Chen, Yawen Guo, Chao Zhang, Chunping Liu, and Tao Huang
|
| 16271-16271 |
|
| Correction: Unanticipated prognosis of differential thyroid cancer patients with T0 stage: analysis of the SEER database 20042013 |
|
https://doi.org/10.18632/oncotarget.24999
Chunping Liu, Jie Ming, Wen Zeng, Shuntao Wang, Yiquan Xiong, Qiuyang Zhao, Xingjie Yin, Zeming Liu, and Tao Huang
|
| 16272-16272 |
|
| Correction: Propensity score matching analysis of the prognosis for the rare oxyphilic subtype of thyroid cancer Hurthle cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25000
Yiquan Xiong, Qiuyang Zhao, Zhi Li, Shuntao Wang, Hui Guo, Zeming Liu, and Tao Huang
|
| 16273-16273 |
|
| Correction: Mixed subtype thyroid cancer: A surveillance epidemiology and end results database analysis |
|
https://doi.org/10.18632/oncotarget.25001
Chunping Liu, Qiuyang Zhao, Zhi Li, Shuntao Wang, Yiquan Xiong, Zeming Liu, and Tao Huang
|
| 16274-16274 |
